Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Akutsu

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 1987
[Treatment of malignant lymphoma: 12 years' experience with 109 patients. 2). Treatment of non-Hodgkin's lymphoma]Y Furukawa, S Takagi, A Tsuboyama, et al.
Leukemia|March 3, 2007
Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus -negative leukemia cell linesY Furukawa, H A Vu, M Akutsu, et al.
Journal of Nanoscience and Nanotechnology|March 10, 2012
Drug delivery observation of hydrophobe ferrofluid and magnetite nanoparticals by SPring-8 synchrotron radiationD Y Ju, P Bian, T Kumazawa, et al.
Oncogene|January 10, 2002
Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cellsK Ohmine, J Ota, M Ueda, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 1, 1987
[Treatment of malignant lymphoma: 12 years' experience with 109 patients. 2). Treatment of non-Hodgkin's lymphoma]Y Furukawa, S Takagi, A Tsuboyama, et al.
Leukemia|March 3, 2007
Divergent cytotoxic effects of PKC412 in combination with conventional antileukemic agents in FLT3 mutation-positive versus -negative leukemia cell linesY Furukawa, H A Vu, M Akutsu, et al.
Journal of Nanoscience and Nanotechnology|March 10, 2012
Drug delivery observation of hydrophobe ferrofluid and magnetite nanoparticals by SPring-8 synchrotron radiationD Y Ju, P Bian, T Kumazawa, et al.
Oncogene|January 10, 2002
Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cellsK Ohmine, J Ota, M Ueda, et al.
Pageof 6